ATL/Interspec regroups after merger

Article

Ultrasound vendors ATL andInterspec have begun to reap benefits from their just-finalizedmerger. ATL's HDI CV cardiology ultrasound system was displayedat the Interspec booth at the American Society of Echocardiographyconference in San Francisco last

Ultrasound vendors ATL andInterspec have begun to reap benefits from their just-finalizedmerger. ATL's HDI CV cardiology ultrasound system was displayedat the Interspec booth at the American Society of Echocardiographyconference in San Francisco last month. The cardiology versionof Bothell, WA-based ATL's HDI platform was introduced in Europea year ago (SCAN 2/16/94).

HDI CV will now be handled by Interspec's cardiology-focusedsales force, allowing ATL's U.S. sales group to concentrate onradiology. In turn, Interspec's new Apogee RX400 radiology systemwill become a mid-tier offering in ATL's radiology line, positionedbeneath the premium Ultramark 9 HDI.

HDI CV was shown at the ASE meeting with two new probes. However,the enlarged ATL company has not yet combined Interspec technologywith its own. An Interspec-designed multifrequency pediatric transducerfor the HDI cardiac scanner should be coming soon.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.